March 2024 – Rupendra SHRESTHA Ph.D.

Exploring platelet-derived microvesicles in vascular regeneration: unraveling the intricate mechanisms and molecular mediators

Rupendra Shrestha March 8, 2024

Ranjith Balakrishnan 1, Rajasekaran Subbarayan 2*, Rupendra Shrestha 3*, Ankush Chauhan 4, Loganathan Krishnamoorthy 5 Centre for Advanced Biotherapeutics and...

Month: March 2024

Exploring platelet-derived microvesicles in vascular regeneration: unraveling the intricate mechanisms and molecular mediators

The Impact of SARS-CoV-2 on Liver Diseases and Potential Phytochemical Treatments

Six3 and Six6 jointly control diverse target genes in multiple cell populations over developmental trajectories of mouse embryonic retinal progenitor cells

Construction of pVAX-1-based linear covalently closed vector with improved transgene expression

Molecular insights on Eltrombopag: potential mitogen stimulants, angiogenesis, and therapeutic radioprotectant through TPO-R activation

Conditioned medium-enriched umbilical cord mesenchymal stem cells: a potential therapeutic strategy for spinal cord injury, unveiling transcriptomic and secretomic insights

नेपालि मिति

Calendar

Recent Posts

Archives

TESTIMONIALS

Masayo Takahashi: Led the World’s First iPSC-RPE Clinical Trials

Kapil Bharti: Developed 3D Vascularized Ocular Tissue for Cell Therapy

SRU Center for Regenerative Medicine

Poster Presentation

Best Paper Award

ISSCR Travel Award

Experimental Eye Research Team

Exploring platelet-derived microvesicles in vascular regeneration: unraveling the intricate mechanisms and molecular mediators

You may have missed

The Impact of SARS-CoV-2 on Liver Diseases and Potential Phytochemical Treatments

Six3 and Six6 jointly control diverse target genes in multiple cell populations over developmental trajectories of mouse embryonic retinal progenitor cells

Construction of pVAX-1-based linear covalently closed vector with improved transgene expression

Molecular insights on Eltrombopag: potential mitogen stimulants, angiogenesis, and therapeutic radioprotectant through TPO-R activation

Conditioned medium-enriched umbilical cord mesenchymal stem cells: a potential therapeutic strategy for spinal cord injury, unveiling transcriptomic and secretomic insights

नेपालि मिति

Calendar

Recent Posts

Archives

TESTIMONIALS

Masayo Takahashi: Led the World’s First iPSC-RPE Clinical Trials

Kapil Bharti: Developed 3D Vascularized Ocular Tissue for Cell Therapy

SRU Center for Regenerative Medicine

Poster Presentation

Best Paper Award

ISSCR Travel Award

Experimental Eye Research Team